4 a-f), showing a highly significant reduction of all the markers analyzed (80–90%) compared to the LPS-treated samples: CXCL-1 (21.41 ± 11.43%), iNOS (21.89 ± 9.18%), IL-6 (11.77 ± 6.66%), IL-8 (13.72 ± 0.75%), MMP-3 (12.79 ± 7.84%) and MMP-13 (21.20 ± 3.36%).
← all excerpts
Unveiling the therapeutic potential of phenolic compounds from Boletus edulis in osteoarthritis treatment.
1
—
—